Sodium oxybate (SXB), first developed in the 1960s, is a central nervous system depressant recommended by the American Academy of Sleep Medicine, European guidelines, and expert statements for the treatment …
A rare genetic variant in the cleavage site of prepro-orexin is associated with idiopathic hypersomnia
Idiopathic hypersomnia (IH) is a rare heterogeneous disorder characterized by prolonged and disabling excessive daytime sleepiness (intolerable sleepiness in the daytime)1. Patients with narcolepsy type 1, which is a well-recognized …
Associations of late-life sleep medication use with incident dementia in the Atherosclerosis Risk in Communities (ARIC) Study
Sleep medications may contribute to dementia development or indicate sleep disturbances that are markers of or contributors to neurologic disease. The objective of this study was to examine the use …
Frequency of use and preferences for information and communication technologies in patients with sleep apnea: A multicenter, multinational, observational cross-sectional survey study
Obstructive sleep apnea (OSA) is a condition characterized by repeated episodes of partial or complete obstruction of the upper airway during sleep. An accessible method to facilitate self-management education is …
Light exposure during sleep may alter glucose metabolism and impair cardiometabolic function
1. In this study, one night of moderate light exposure (100 lx) during sleep was associated with increased sympathetic nervous system activation, and in turn, increased next-morning insulin resistance, compared …